04:14 PM EDT, 05/17/2024 (MT Newswires) -- George Yancopoulos, Director, Board Co-Chair, President & Chief Scientific Officer, on May 16, 2024, sold 50,000 shares in Regeneron Pharmaceuticals ( REGN ) for $48,636,545. Following the Form 4 filing with the SEC, Yancopoulos has control over a total of 1,148,844 shares of the company, with 786,383 shares held directly and 362,461 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/872589/000196820224000094/xslF345X03/edgardoc.xml